| 前收盘价格 | 8.42 |
| 收盘价格 | 8.30 |
| 成交量 | 10,319 |
| 平均成交量 (3个月) | 32,141 |
| 市值 | 73,071,648 |
| 价格/销量 (P/S) | 0.040 |
| 52周波幅 | |
| 利润日期 | 21 May 2025 - 26 May 2025 |
| 营业毛利率 | -0.45% |
| 营业利益率 (TTM) | -0.19% |
| 稀释每股收益 (EPS TTM) | -1.03 |
| 季度收入增长率 (YOY) | -6.30% |
| 总债务/股东权益 (D/E MRQ) | 56.84% |
| 流动比率 (MRQ) | 1.13 |
| 营业现金流 (OCF TTM) | 263.02 M |
| 杠杆自由现金流 (LFCF TTM) | 106.61 M |
| 资产报酬率 (ROA TTM) | 0.05% |
| 股东权益报酬率 (ROE TTM) | -6.33% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Distribution (US) | 看涨 | 看跌 |
| Medical Distribution (全球的) | 混合的 | 看跌 | |
| 股票 | 111, Inc. | - | - |
AIStockmoo 评分
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | -1.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.0 |
| 平均 | -0.38 |
|
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People’s Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment. |
|
| 部门 | Healthcare |
| 行业 | Medical Distribution |
| 内部持股比例 | 15.87% |
| 机构持股比例 | 28.85% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Harbourvest Partners Llc | 31 Dec 2024 | 90,312 |
| Napean Trading & Investment Co (Singapore) Pte Ltd | 31 Dec 2024 | 39,316 |
| Railway Pension Investments Ltd | 31 Dec 2024 | 25,723 |
| Parafestas Anastasios | 31 Dec 2024 | 13,616 |
| Serenus Wealth Advisors, Llc | 31 Dec 2024 | 4,563 |
| Pathstone Holdings, Llc | 31 Dec 2024 | 2,723 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合